Skip to main content
. 2023 Mar 7;4(1):zpad016. doi: 10.1093/sleepadvances/zpad016

Table 1.

Patient characteristics at baseline screening

Sample size 18
Age in years (M ± SD, range) 28.72 ± 4.65, 18–37
Gestational age (M ± SD, range) 20.44 ± 3.01, 16–26
Race
 Non-Hispanic Black (n; %) 8/18; 44.4%
 Non-Hispanic white (n; %) 8/18; 44.4%
 Multiracial 2/18; 11.1%
Poverty (n; %) 3/18; 16.7%
BMI (M ± SD) 28.56 ± 5.55
 BMI ≥35 (n; %) 2/17; 11.8%
Relationship status (n; %)
 Single 2/18; 11.1%
 Unmarried, but in a relationship 7/18; 38.9%
 Married 9/18; 50.0%
Multiparous (n; %) 12/18; 66.7%
Snore (n; %) 2/18; 11.1%
DSM-5 insomnia disorder (n; %) 12/18; 66.7%
ISI (M ± SD) 13.78 ± 3.86
Habitual bedtime (median; range) 23:00; 21:00–01:00
Sleep latency, patient-reported minutes (M ± SD) 32.50 ± 26.19
Sleep onset insomnia ≥3 nights/week 6/18; 33.3%
Sleep maintenance insomnia ≥3 nights/week 10/18; 55.6%
Sleep duration, patient-reported hours (M ± SD) 6.25 ± 1.15
 Short sleep (patient-reported ≤6 h; n; %) 11/7; 61.1%
EPDS (M ± SD) 9.28 ± 4.16
 EPDS ≥10 (n; %) 10/18; 55.6%
 Suicidal ideation (n; %) 4/18; 22.2%
PSASC (M ± SD) 21.50 ± 7.61
 PSASC ≥18 (n; %) 12/18; 66.7%

BMI, body mass index; M ± SD, mean and standard deviation; n, number of participants; %, percentage of sample. Poverty operationalized as ≤$20 000 in annual income. Sleep latency, sleep onset insomnia, sleep maintenance insomnia, and sleep duration were derived from the Pittsburgh Sleep Quality Index. Suicidal ideation assessed by EPDS item #10 such that any endorsement is a positive screen.